Cardiovascular Stents Market to Reach Us$ 13,100.2 Mn by 2025, Introduction of Next Generation Drugs to Boost Market, says Fortune Business Insights
In terms of stent type, the drug eluting stents segment is expected to hold a larger share of the market, hence booking the dominant position. This dominance is attributable to key companies introducing next-generation drugs for drug eluting systems (DES), and is likely to continue in the coming years.
With respect to end users, the hospitals segment holds dominance in the global market as it registers the highest consumption of cardiovascular stents.
Request a Sample Copy of the Research Report
An Overview of the Impact of COVID-19 on this Market:
The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.
We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.
Increasing Number of Cardiovascular Cases to Fuel Demand in Market
In 2017, coronary stents surgery was the most common treatment among cardiovascular patients with a market share of 66.9%. The rising number of cardiovascular diseases worldwide is expected to drive the global market, as per analysts at Fortune Business Insights.
Besides this, huge investments made by market players in research and development on environmental and decomposable coronary stents is also anticipated to boost the market.
Unhealthy lifestyle and irregular eating habits of people have led to have increased the prevalence of health-related concerns, including chronic diseases such as diabetes, obesity, and heart disorders. The surging cases of heart disorder is continuously fueling the demand for treating heart problems including angioplasty, which ultimately increased the demand for cardiovascular stents.
However, the market may face challenges due to the presence of alternative treatment methods for vascular diseases. Again, the complexity of cardiovascular stent implantation may cause patients to opt for other treatment options and this may restrict growth in the market. Besides this, incident of product recalls and failures may also hamper the market in future.
Nevertheless, the emerging markets for cardiovascular stents and their rapid accent is likely to boost growth opportunities for the market in the long run. Again, the development of bioresorbable stents will help the cardiovascular stents market to grow remarkably in the future.
Quick Buy Cardiovascular Stents Market
Alpine Stent to Open Growth Opportunities for Market in Asia Pacific
The cardiovascular stents market in North America was emerged dominant and was valued at US$ 2,344.9 Mn in 2017. This is mainly due to the presence of better medical facilities and skilled professionals in the developed nations of Canada and the U.S. North America is likely to remain dominant in the coming years as well on account of ongoing clinical trials on novel stents in the U.S. and various regulatory approvals on cardiovascular stents.
The market for cardiovascular stents in Asia Pacific is likely to show growth at a higher rate on account of improved distribution of cardiovascular stents in emerging economies such as China and India. In order to improve their accessibility, price capping of stents is introduced in these developing nations and this will help the market gain momentum. Thus, Asia Pacific is likely to register itself as the fastest growing region in the during the forecast tenure.
Various companies operating in the global cardiovascular stents market are B. Braun Melsungen AG, Cardinal Health, C. R. Bard, Inc., Terumo Corporation, MicroPort Scientific Corporation, and others. Major vendors are focusing on investing in clinical studies and research and development of better stents. At present, Boston Scientific Corporation, Abbott, and Medtronic, are leading the market.
Have Any Query? Ask Our Experts
Key Segments Within the Market
By Procedure Type
Drug Eluting Stents (DES)
Bare Metal Stents
By Stent Type
By Disease Indication
Ambulatory Surgery Centers
By End User
North America (USA and Canada)
Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune - 411045, Maharashtra, India.
US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
LinkedIn | Twitter | Blogs
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cardiovascular Stents Market to Reach Us$ 13,100.2 Mn by 2025, Introduction of Next Generation Drugs to Boost Market, says Fortune Business Insights here
News-ID: 2368779 • Views: 151
More Releases from Fortune Business Insights
Genomic Market to rising at 18.7% CAGR by Top Players | Illumina, Inc., Thermo F …
Genomics Market Size | 2021 Covid-19 Impact On Healthcare Industry Global Analysis By Size, Trends, Growth, Share, Business, Key Players, Merger, Statistics, Competitive Landscape, And Regional Forecast To 2028 is latest study published by Fortune Business Insights. The Global Genomics market expected to rise at notable CAGR and reach remarkable valuations by 2028. Genomics Industry is segmented By Type (Products, Services), Technology (Polymerase Chain Reaction, Next-generation Sequencing, Microarray, Sanger Sequencing),
U.S. Biosimilars Market Set For Rapid Growth Forecast 2020-2026| Key Players: F. …
U.S. Biosimilars Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The “U.S. Biosimilars Market” will gain momentum from the increasing government support to adopt biosimilars in the healthcare sectors. According to a report by Fortune Business Insights, titled, “Biosimilars: U.S. Market Analysis, Insights and Forecast, 2019-2026,” The U.S. Biosimilars Market is projected to reach US$ 17,696.0 Mn by 2026. The report provides valuable
Pulse Oximeters Market by Key Players are Omron Healthcare, Inc., Philips Benelu …
Pulse Oximeters Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The Global Pulse Oximeters Market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled “Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025,” the market is likely to reach US$ 2,657.6 Mn
Orthopedic Joint Replacement Market by Top International Players | Integra LifeS …
Orthopedic Joint Replacement Market | 2021 Size, Growth, Share, Cap, Regional Analysis With Global Industry Forecast To 2027. The global orthopedic joint replacement market size is poised to reach USD 26,967.9 million by 2026, exhibiting a CAGR of 5.1% during the forecast period. Combined rise in the incidence of osteoarthritis and geriatric population in the world will be the key force behind the growth of this market. Osteoarthritis is a lifelong
More Releases for Stent
Bio-engineered Stent Market Revolutionary Opportunities 2028
Global Bio-engineered Stent Market: Overview The global bio-engineered stent market has grown steadily over the years, due to the advantages it provides to the heart patients. Bio-engineered stents are a type of device which consist of short plastic tube or narrow metal. These devices are extensively used in order to treat blocked arteries. Therefore, bio-engineered stent is gaining its maximum popularity among the patients who are suffering from several types of
Gel Stent Markets- gel stent market include AqueSysInc. and ALLERGAN.
The Zion Market Research added a new report “Gel Stent Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market players, segmentation and forecasting. Gel Stent Market Market research report which provides an in-depth examination of the market scenario regarding market size, share,
Stent Grafts Market : Foraying into Emerging Economies
A stent graft is a tube shaped device composed of a rigid structure called a stent (mostly a metal) and a special fabric covering the stent. A stent is a metal mesh without any covering but a stent graft has a fabric covering and is mainly used in endovascular surgeries. A stent graft is used to repair abdominal aortic aneurysm (AAA) in a procedure called as endovascular aneurysm repair (EVAR).
Coronary Stent Market Influential Share of 2025
Global Coronary Stent Market: Overview The alarming rise in the number of cardiovascular diseases has become the primary growth driver for the global coronary stent market. Changing lifestyles that are characterized by high stress levels, alcohol consumption, smoking, and poor choice of food habits have collectively led to questionable heart health for the global market. The World Health Organization states that the cardiovascular diseases have become the leading cause of deaths
Stent Grafts Global Market For 2017: By Application - Peripheral Stent Grafts, A …
Researchmoz added Most up-to-date research on "Stent Grafts Global Market For 2017: By Application - Peripheral Stent Grafts, Aortic Stent Grafts & Other" to its huge collection of research reports. This report studies Stent Grafts in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022. This report focuses on top
Global EVAR Stent Grafts Sales Market: By Product Type - Abdominal Aortic Stent …
Researchmoz added Most up-to-date research on "Global EVAR Stent Grafts Sales Market: By Product Type - Abdominal Aortic Stent Grafts & Thoracic Aortic Stent Grafts" to its huge collection of research reports. This report studies sales (consumption) of EVAR Stent Grafts in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions,